2024 Minnesota Statutes

152.24 FEDERALLY APPROVED CLINICAL TRIALS.

The commissioner may prohibit enrollment of a patient in the registry program if the patient is simultaneously enrolled in a federally approved clinical trial for the treatment of a qualifying medical condition with medical cannabis. The commissioner shall provide information to all patients enrolled in the registry program on the existence of federally approved clinical trials for the treatment of the patient's qualifying medical condition with medical cannabis as an alternative to enrollment in the patient registry program.

History:

2014 c 311 s 4

NOTE: This section is repealed by Laws 2023, chapter 63, article 6, section 73, effective December 1, 2025. Laws 2023, chapter 63, article 6, section 73, the effective date, as amended by Laws 2024, chapter 121, article 2, section 147.